Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
-1.01 %
$ 42.2 M
Market Cap
-2.2
P/E
LTRN - COST OF REVENUE
Cost of Revenue LTRN - Lantern Pharma Inc.
175 K
LAST VALUE
33.97%
2 YEAR CAGR
134.38%
5 YEAR CAGR
0.00%
10 YEAR CAGR